Posted 14 June, 2021
IOVANCE BIOTHERAPEUTICS, INC. appointed new CEO
CEO Change detected for ticker Nasdaq:IOVA in a 8-K filed on 14 June, 2021.
As previously disclosed, on May 18, 2021, Maria Fardis, Ph.D., MBA notified the Company (as defined below) that she would be resigning as President, Chief Executive Officer and a director of the Company to pursue other opportunities.
Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of IOVANCE BIOTHERAPEUTICS, INC.
Relevant filing section
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As previously disclosed, on May 18, 2021, Maria Fardis, Ph.D., MBA notified the Company (as defined below) that she would be resigning as President, Chief Executive Officer and a director of the Company to pursue other opportunities. Dr. Fardis' last day as a director and employee of the Company will be on June 18, 2021.
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.